Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Pfizer has completed its acquisition of Anacor Pharmaceuticals, Inc. Under the terms of the transaction, each outstanding share of Anacor common stock has been converted into the right to receive $99.25 net in cash (without interest but subject to ...
read more
Wednesday, March 07, 2018
Pfizer CentreOne announced the introduction of Enviero progesterone into the API marketplace.
read more
Friday, February 17, 2017
Pfizer CentreOne, a global contract manufacturing organization embedded within Pfizer, has expanded its fill-finish services to its Kalamazoo, Michigan (United States), site. Along with vial-filling of small molecules and biologics, the facility ...
read more
Wednesday, October 18, 2017
Pfizer CentreOne announced that it is now offering services in Nagoya, Japan.
read more
Pfizer CentreOne has grown its service portfolio to include contract manufacturing of highly potent solid oral dose medicines. The service will be provided at the Pfizer Newbridge, Ireland, facility, which is now part of Pfizer CentreOne’s contract ...
read more
Friday, December 11, 2015
Catalent Pharma Solutions, a global provider of advanced delivery technologies and development solutions for drugs, biologics, consumer health and animal health products, has entered into an exclusive long term supply agreement to produce Pfizer Inc....
read more
Thursday, August 29, 2019
Pfizer announced an additional half billion dollar investment for the construction of its state-of-the-art gene therapy manufacturing facility in Sanford, North Carolina.
read more
Pfizer announced the closing of its joint venture with GlaxoSmithKline to combine and create the world’s largest OTC business.
read more
ICON plc (NASDAQ: ICLR), today announced that Pfizer and Roche have joined the ADDPLAN® DF Consortium. The consortium was founded in 2013 by Novartis Pharma AG, Janssen Pharmaceuticals Inc., Eli Lilly, and Aptiv Solutions, which is an ICON plc ...
read more
Wednesday, December 18, 2019
Pfenex has earned a $15 million development milestone under its development and license agreement with Jazz Pharmaceuticals.
read more
Thursday, August 29, 2013
Packaging Coordinators Inc (PCI) is pleased to announce that Peter Belden has assumed the role of General Manager for its Rockford, IL based facilities. PCI operates nine facilities in Rockford, totaling over 1,000,000 square feet and employing over...
read more
Tuesday, October 10, 2017
Pertinax Pharma announced the commercial launch of its proprietary Pertinax technology, which provides controlled and sustained delivery of CHX.
read more
Friday, November 09, 2018
Personalis announced the launch of its universal cancer immunogenomics platform, ImmunoID NeXT.
read more
Wednesday, November 20, 2019
Personalis has announced a collaboration with Merck KGaA, Darmstadt, Germany to investigate novel biomarkers of response and mechanisms of resistance to cancer therapies.
read more
Friday, February 03, 2023
Personalis, Inc., a provider of advanced genomics for precision oncology, and Moderna, Inc. announced the companies have signed a new agreement to continue using the Personalis NeXT Platform® as part of upcoming clinical studies evaluating mRNA-4157/...
read more